Literature DB >> 3322960

Renal function in fulminant hepatic failure: haemodynamics and renal prostaglandins.

F Guarner1, R D Hughes, A E Gimson, R Williams.   

Abstract

Eighteen patients with fulminant liver failure were studied, 10 with normal renal function (group A) and eight with renal failure (group B, plasma creatinine greater than 200 mumol/l). Renal function was assessed by standard clearance techniques and patients in group B had a marked reduction compared with group A in both renal plasma flow and glomerular filtration rate. Raised plasma renin activity was observed in both groups, but levels in group B were significantly higher than in group A. Renal prostacyclin production was estimated by radioimmunoassay (RIA) of 6-keto-prostaglandin F1 alpha in urine, and the excretion rate was markedly increased in group A as compared with nine healthy controls, but was low in group B. The plasma concentrations of 6-keto-prostaglandin F1 alpha and thromboxane B2 were similar in groups A and B and were both significantly higher than in controls. Haemodynamic measurements showed a high cardiac output with low vascular resistance and mean arterial pressure within normal limits in both groups. The pulse pressure, however, was significantly higher in group B than in group A. In conclusion, patients in FHF with renal failure have marked renal vasoconstriction with increased plasma renin activity and reduced renal prostaglandin excretion indicative of an imbalance between vasoactive forces.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3322960      PMCID: PMC1433928          DOI: 10.1136/gut.28.12.1643

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Pathogenesis of renal failure in cirrhosis and fulminant hepatic failure.

Authors:  S P Wilkinson; B Portmann; D Hurst; R Williams
Journal:  Postgrad Med J       Date:  1975-08       Impact factor: 2.401

Review 2.  Prostacyclin: its biosynthesis, actions, and clinical potential.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1982

3.  Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.

Authors:  G A FitzGerald; A K Pedersen; C Patrono
Journal:  Circulation       Date:  1983-06       Impact factor: 29.690

4.  Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease.

Authors:  R D Zipser; J C Hoefs; P F Speckart; P K Zia; R Horton
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

5.  Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease.

Authors:  T D Boyer; P Zia; T B Reynolds
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

6.  Renal prostaglandins in cirrhosis of the liver.

Authors:  C Guarner; I Colina; F Guarner; J Corzo; J Prieto; F Vilardell
Journal:  Clin Sci (Lond)       Date:  1986-05       Impact factor: 6.124

7.  Renin-angiotensin-aldosterone system in cirrhosis.

Authors:  S P Wilkinson; R Williams
Journal:  Gut       Date:  1980-06       Impact factor: 23.059

8.  Pathophysiology of hypotension in patients with fulminant hepatic failure.

Authors:  P N Trewby; R Williams
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

9.  Platelet adhesiveness to glass beads in liver disease.

Authors:  P G Langley; R D Hughes; R Williams
Journal:  Acta Haematol       Date:  1982       Impact factor: 2.195

10.  Evidence for a direct stimulatory effect of prostacyclin on renin release in man.

Authors:  C Patrono; F Pugliese; G Ciabattoni; P Patrignani; A Maseri; S Chierchia; B A Peskar; G A Cinotti; B M Simonetti; A Pierucci
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

View more
  7 in total

1.  Portal hypertension in acute liver failure.

Authors:  M Navasa; J C Garcia-Pagán; J Bosch; J R Riera; R Bañares; A Mas; M Bruguera; J Rodés
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Hepatosplanchnic haemodynamics and renal blood flow and function in rats with liver failure.

Authors:  P Javlé; J Yates; H G Kynaston; K F Parsons; S A Jenkins
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

3.  Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure.

Authors:  R Anand; D Harry; S Holt; P Milner; M Dashwood; D Goodier; M Jarmulowicz; K Moore
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

4.  Cyclooxygenase-2 and inducible nitric oxide synthase in omental arteries harvested from patients with severe liver diseases: immuno-localization and influence on vascular tone.

Authors:  Antonia Tabernero; Francis Schneider; Maria Assunta Potenza; Voahanginirina Randriamboavonjy; Sylvette Chasserot; Philippe Wolf; Delia Mitolo-Chieppa; Jean-Claude Stoclet; Ramaroson Andriantsitohaina
Journal:  Intensive Care Med       Date:  2003-01-15       Impact factor: 17.440

5.  Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure.

Authors:  M Z Panos; J V Anderson; A Forbes; N Payne; J D Slater; L Rees; R Williams
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

6.  Protective effects of ellagic acid in D-galactosamine-induced kidney damage in rats.

Authors:  Adnan Ayhanci; Mustafa Cengiz; H Mehtap Kutlu; Djanan Vejselova
Journal:  Cytotechnology       Date:  2015-12-12       Impact factor: 2.058

7.  Amelioration of galactosamine-induced nephrotoxicity by a protein isolated from the leaves of the herb, Cajanus indicus L.

Authors:  Mahua Sinha; Prasenjit Manna; Parames C Sil
Journal:  BMC Complement Altern Med       Date:  2007-04-25       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.